|
1
|
Yadav D and Lowenfels AB: The epidemiology
of pancreatitis and pancreatic cancer. Gastroenterology.
144:1252–1261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ghadirian P, Lynch HT and Krewski D:
Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev.
27:87–93. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han H and Von Hoff DD: SnapShot:
pancreatic cancer. Cancer Cell. 23:424. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamashita A, Ohnishi T, Kashima I, Taya Y
and Ohno S: Human SMG-1, a novel phosphatidylinositol
3-kinase-related protein kinase, associates with components of the
mRNA surveillance complex and is involved in the regulation of
nonsense-mediated mRNA decay. Genes Dev. 15:2215–2228. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Denning G, Jamieson L, Maquat LE, Thompson
EA and Fields AP: Cloning of a novel phosphatidylinositol
kinase-related kinase: characterization of the human SMG-1 RNA
surveillance protein. J Biol Chem. 276:22709–22714. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gehen SC, Staversky RJ, Bambara RA, Keng
PC and O’Reilly MA: hSMG-1 and ATM sequentially and independently
regulate the G1 checkpoint during oxidative stress. Oncogene.
27:4065–4074. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brumbaugh KM, Otterness DM, Geisen C, et
al: The mRNA surveillance protein hSMG-1 functions in genotoxic
stress response pathways in mammalian cells. Mol Cell. 14:585–598.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Greenman C, Stephens P, Smith R, et al:
Patterns of somatic mutation in human cancer genomes. Nature.
446:153–158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Uhlen M, Oksvold P, Fagerberg L, et al:
Towards a knowledge-based Human Protein Atlas. Nat Biotechnol.
28:1248–1250. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gubanova E, Issaeva N, Gokturk C,
Djureinovic T and Helleday T: SMG-1 suppresses CDK2 and tumor
growth by regulating both the p53 and Cdc25A signaling pathways.
Cell Cycle. 12:3770–3780. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Erker L, Schubert R, Yakushiji H, et al:
Cancer chemoprevention by the antioxidant tempol acts partially via
the p53 tumor suppressor. Hum Mol Genet. 14:1699–1708. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gubanova E, Brown B, Ivanov SV, et al:
Downregulation of SMG-1 in HPV-positive head and neck squamous cell
carcinoma due to promoter hypermethylation correlates with improved
survival. Clin Cancer Res. 18:1257–1267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oliveira V, Romanow WJ, Geisen C, et al: A
protective role for the human SMG-1 kinase against tumor necrosis
factor-α-induced apoptosis. J Biol Chem. 283:13174–13184. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tiedemann RE, Zhu YX, Schmidt J, et al:
Kinome-wide RNAi studies in human multiple myeloma identify
vulnerable kinase targets, including a lymphoid-restricted kinase,
GRK6. Blood. 115:1594–1604. 2010. View Article : Google Scholar :
|
|
15
|
Neben K, Schnittger S, Brors B, et al:
Distinct gene expression patterns associated with FLT3- and
NRAS-activating mutations in acute myeloid leukemia with normal
karyotype. Oncogene. 24:1580–1588. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Chen RQ, Yang QK, Chen YL, et al: Kinome
siRNA screen identifies SMG-1 as a negative regulator of
hypoxia-inducible factor-1α in hypoxia. J Biol Chem.
284:16752–16758. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Noensie EN and Dietz HC: A strategy for
disease gene identification through nonsense-mediated mRNA decay
inhibition. Nat Biotechnol. 19:434–439. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Perrin-Vidoz L, Sinilnikova OM,
Stoppa-Lyonnet D, Lenoir GM and Mazoyer S: The nonsense-mediated
mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing
premature termination codons. Hum Mol Genet. 11:2805–2814. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
González-Estévez C, Felix DA, Smith MD, et
al: SMG-1 and mTORC1 act antagonistically to regulate response to
injury and growth in planarians. PLoS Genet. 8:e10026192012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roberts TL, Ho U, Luff J, et al: Smg1
haploinsufficiency predisposes to tumor formation and inflammation.
Proc Natl Acad Sci USA. 110:E285–294. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Masse I, Molin L, Mouchiroud L, et al: A
novel role for the SMG-1 kinase in lifespan and oxidative stress
resistance in Caenorhabditis elegans. PLoS One. 3:e33542008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abraham RT: PI 3-kinase related kinases:
‘big’ players in stress-induced signaling pathways. DNA Repair
(Amst). 3:883–887. 2004. View Article : Google Scholar
|
|
24
|
Brummelkamp TR, Bernards R and Agami R: A
system for stable expression of short interfering RNAs in mammalian
cells. Science. 296:550–553. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Philip PA: Targeted therapies for
pancreatic cancer. Gastrointest Cancer Res. 2:S16–S19. 2008.
|
|
26
|
Xia QS, Li YZ, Li HY, et al: Effect of
inhibiting the expression of hSMG-1 on chemosensitivity of human
non-small cell lung cancer H1299 cells. Zhonghua Yi Xue Za Zhi.
91:554–559. 2011.In Chinese. PubMed/NCBI
|
